News

CHO Plus, Inc. ( a leading developer of biopharmaceutical manufacturing technology, announces that U.S. Patent No. 12,270,055 ...
Quantum technology will fundamentally change the landscape in finance, medicine, and fusion research, among other fields. But ...
Bo Wang is a renowned AI scientist at the University of Toronto. He’s bringing his open-source culture and computational ...
SHANGHAI, April 11 (Xinhua) -- China has approved its first gene therapy for hemophilia B, an inherited bleeding disorder caused by the deficiency of the clotting protein factor IX ...
Another company looking to initiate clinical trials with an epigenetic-editor-based treatment for hepatitis is nChroma Bio.
Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment.
Pilgrim's Pride shows strong growth potential with global chicken demand and automation support. Find out why PPC stock is a ...
MULGONET combines deep learning and multi-omics analysis to predict tumor recurrence, addressing interpretability and ...
8, 2025 — Scientists have pioneered an influenza virus vector-based nasal spray vaccine ... Single Mutation in H5N1 Influenza Surface Protein Could Enable Easier Human Infection Dec. 6, 2024 ...
facility in Plainville provides viral vector services ranging from process development ... in the U.S. Sanofi’s pipeline reprioritization project to simplify its R&D structure will result in layoffs ...
Proteins form the structural and functional backbone of the cell, and any perturbation in their synthesis can disrupt normal ...